Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
about
Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in miceStem-like ovarian cancer cells can serve as tumor vascular progenitorsTargeting NRASQ61K mutant delays tumor growth and angiogenesis in non-small cell lung cancerThe proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents.Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells.Migration and vascular lumen formation of endothelial cells in cancer cell spheroids of various sizes.URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.siRNA-mediated inhibition of angiogenesis.Clinical implications of DLL4 expression in gastric cancerRegulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interferenceFrom bench to bedside: the growing use of translational research in cancer medicine.Endothelial progenitor cells contribute to the development of ovarian carcinoma tumor blood vesselsHypoxia inducible factor-1 alpha and multiple myeloma.SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab.Angiopoietins as biomarker of disease activity and response to therapy in multiple myeloma.Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells.The prognostic significance of vasohibin-1 expression in patients with prostate cancerVasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer.
P2860
Q24799034-C6CEF3C0-6D90-40A9-9363-73AF5C5DADC9Q30446280-3649076E-D804-4302-B64D-05B15C77657EQ30491933-88506DAE-ACA1-4626-95F5-FFD2C05D93AFQ33622661-03AA9C4E-403E-4333-93D4-16EF916DC6D1Q34011118-18563AE0-CDA3-4FA5-8DEE-FB20675D09AFQ34210916-743E32A8-0977-454E-B727-2A7189AD6B6FQ34305816-37A00B00-0912-41CE-B9A9-41831B444D45Q35623604-ABC495F4-F15D-4FEF-BFEC-D3F367ECAB9EQ36099464-DC6DC3E1-9DC4-4575-A03A-E81D411CCB65Q37114635-639A57CB-64EC-4D25-8423-8C278602A05AQ37555005-3AD26A73-C9A8-440D-A336-41C999E0C010Q37698244-8F3C176F-446A-4DD4-A78F-7A878BE35F48Q37720004-208694ED-C547-4310-A13D-D11FB99074F1Q38567828-9B662FDF-C377-4882-8E20-D6B2B27D60A1Q39350876-5992020C-3E08-49AA-AF45-D5CB0AB9E2A5Q39423599-A96E88CB-F1D9-42D5-B8DE-F750188B6838Q39527767-6606E106-A847-4E3F-9284-BB3603703982Q40014606-CE63C5B5-D27D-4129-B1ED-08499C1C10BFQ41418421-5BEC527F-4423-4E56-81E1-6175D7AB59B7Q51763367-62A4C2BF-00B4-4CE0-A500-B058257E9F8D
P2860
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
@ast
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
@en
type
label
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
@ast
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
@en
prefLabel
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
@ast
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
@en
P1476
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
@en
P2093
Yasufumi Sato
P2888
P304
P356
10.1007/S10147-003-0342-8
P577
2003-08-01T00:00:00Z